Initiative Capital
4
25M
4
0.16
2
- Stages of investment
- Areas of investment
Summary
Initiative Capital appeared to be the VC, which was created in 1997. The venture was found in Europe in France. The main office of represented VC is situated in the Sausheim.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2004. The fund is generally included in less than 2 deals every year. Opposing the other organizations, this Initiative Capital works on 21 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2013.
We can highlight the next thriving fund investment areas, such as Internet, Biopharma. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Addex Therapeutics, Dartfish, Xigen For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Initiative Capital, startups are often financed by Neomed Management, Ysios Capital, VI Partners AG. The meaningful sponsors for the fund in investment in the same round are VI Partners AG, Ysios Capital, Venture Partners. In the next rounds fund is usually obtained by Ysios Capital, Varuma AG, VI Partners AG.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.16
- Investments by industry
- Health Care (3)
- Biotechnology (3)
- Therapeutics (2)
- Surgical Devices (1)
- Medical Device (1) Show 7 more
- Investments by region
-
- Switzerland (4)
- Peak activity year
- 2012
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 42M
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
- Avg. multiplicator
- 1.14
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Addex Therapeutics | 17 May 2004 | Biotechnology, Health Care, Medical, Pharmaceutical | Early Stage Venture | 38M | Switzerland, Geneva |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.